Vomiting; fever 100.8; soreness-swelling and hot to touch of injection site; soreness-swelling and hot to touch of injection site; soreness-swelling and hot to touch of injection site; extreme fatigue/tiredness; stomach ache; nausea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 14 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Jun2021 12:00 (Batch/Lot number: unknown) at the age of 14 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Known allergies: nystatin, reaction(s): "Known allergies: Nystatin", notes: Known allergies: Nystatin. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizerbiontech 30 susp #0.3 EW0191,, lot unknown=True,, lot unknown reason=Unable to locate or read the details,, administration time=12:00 AM,, dose number=1,, vaccine location=Left arm), administration date: 05Jun2021, when the patient was 14 years old, for covid-19 immunization. The following information was reported: VOMITING (non-serious) with onset 27Jun2021 05:00, outcome "not recovered", described as "Vomiting"; PYREXIA (non-serious) with onset 27Jun2021 05:00, outcome "not recovered", described as "fever 100.8"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset 27Jun2021 05:00, outcome "not recovered" and all described as "soreness-swelling and hot to touch of injection site"; FATIGUE (non-serious) with onset 27Jun2021 05:00, outcome "not recovered", described as "extreme fatigue/tiredness"; ABDOMINAL PAIN UPPER (non-serious) with onset 27Jun2021 05:00, outcome "not recovered", described as "stomach ache"; NAUSEA (non-serious) with onset 27Jun2021 05:00, outcome "not recovered", described as "nausea". The events "vomiting", "fever 100.8", "soreness-swelling and hot to touch of injection site", "soreness-swelling and hot to touch of injection site", "soreness-swelling and hot to touch of injection site", "extreme fatigue/tiredness", "stomach ache" and "nausea" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vomiting, pyrexia, vaccination site pain, vaccination site swelling, vaccination site warmth, fatigue, abdominal pain upper, nausea.  Additional Information: Facility type vaccine: Pharmacy or Drug Store. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Vomiting, fever 100.8, soreness swelling and hot to touch of injection site, tiredness, extreme fatigue, stomach ache, nausea all came on around 5 am in the morning of Sunday 27Jun2021. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.